OBGYN Flashcards
PCOS diagnostic criteria?
2/3 of the following present:
- Infrequent or no ovulation (oligomenorrhoea)
- Clinical or biochemical signs of hyperandrogenism or elevated levels of total or free testosterone
- Polycystic ovaries on USS (>12) or increased ovarian volume
Primary vs secondary PPH
Primary within 24hours of delivery (4Ts)
Secondary 24hrs-6 weeks (retained placenta or endometriosis)
Combined test
11 - 13+6
BHCG, PAPP-A, NT
Quadruple test
15-20
AFP, unconjugated oestriol, BHCG, Inhibin A
Criteria for lactational amenorrhea
amenorrhoeic, <6 months post-partum, and breastfeeding exclusively
Diagnosistic TRIAD of Hyperemesis Gravidarum
- 5% pre-pregnancy weight loss
- dehydration
- electrolyte imbalance
Admission criteria for Hyperemesis Gravidarum
- Continued nausea and vomiting and unable to keep down liquids or oral antiemetics
- Continued nausea and vomiting with ketonuria and/or weight loss (>5% of PPBW), despite treatment with oral antiemetics
- A confirmed or suspected comorbidity
Scoring system for ‘nausea and vomiting of pregnancy’ (NVP)
Pregnancy-Unique Quantification of Emesis (PUQE)
Amsel’s criteria for diagnosis of bacterial vaginosis
3/4 should be present:
- thin, white homogenous discharge
- clue cells on microscopy: stippled vaginal epithelial cells
- vaginal pH > 4.5
- positive whiff test (addition of potassium hydroxide results in fishy odour)
BV treatment
Oral metronidazole
Gonorrhoea treatment
IM ceftriaxone
Contraceptives - time until effective (if not first day period)
- instant: IUD
- 2 days: POP
- 7 days: COC, injection, implant, IUS
At which week should you refer to an obstetrician for lack of fetal movements?
24 weeks
Past 28 weeks, when should you refer to an obstetrician for further assessment.
less than 10 movements within 2 hours
MAD POPS
RF for reduced foetal movement
- Medications ie alcohol, benzos, opiates
- Amniotic fluid volume ie. oligo and polyhydramnios
- Distraction
- Posture
- Obesity
- Position of foetus
- Size of foetus
Investigation for reduced foetal movement
Handheld Doppler or ultrasonography
Investigation for reduced foetal movement
>28 weeks = HHD
- No HB → USS
- HB present → CTG for 20mins
24-28 weeks OR <24 weeks and movement felt previously = HHD
CHAT
High risk groups for hypertensive disorders in pregnancy
- chronic kidney disease
- hypertensive disease during previous pregnancies
- autoimmune disorders such as SLE or antiphospholipid syndrome
- type 1 or 2 diabetes mellitus
What should woman who are high risk for Htn in pregnancy be taking
Aspirin 75mg od from 12 weeks until the birth of the baby
Htn in pregnancy values
- systolic > 140 mmHg or diastolic > 90 mmHg
- or an increase above booking readings of > 30 mmHg systolic or > 15 mmHg diastolic
Pre-eclampsia
PIH in association with proteinuria (> 0.3g / 24 hours)
Mx for pyrexia >38 degrees during labour
- Benzylpenicillin as GBS prophylaxis
- Vancomycin if known severe penicillin allergy
- Erythromycin in PPROM
4Ps
RF for GBS infection
- prematurity
- prolonged rupture of the membranes
- previous sibling GBS infection
- Pyrexia e.g. secondary to chorioamnionitis
Preveous GBS detected or preveous baby with GBS disease
- Council re 50% increased risk
- Offer IPA OR
- testing in late pregnancy (if + offer IAP)
Indications to offer IPA
- GBS detected in a previous pregnancy
- Previous baby with GBS disease
- Preterm labour regardless of their GBS status
- Pyrexia during labour (>38ºC)
What bacteria causes GBS
Streptococcus agalacticae (gram + cocci in chains)
Lochia
Vaginal discharge containing blood, mucous and uterine tissue which may continue for 6 weeks after childbirth
Ultrasound indicated if lochia persists >6 weeks
Lochia
Vaginal discharge containing blood, mucous and uterine tissue which may continue for 6 weeks after childbirth
Ultrasound indicated if lochia persists >6 weeks
In what trimester do Intrahepatic cholestasis of pregnancy and fatty liver of pregnancy occur
3rd
Features of Intrahepatic cholestasis of pregnancy
- pruritus, often in palms and soles
- no rash
- raised bilirubin
Mx of Intrahepatic cholestasis of pregnancy
- ursodeoxycholic acid for symptomatic relief
- weekly liver function tests
- Induction at 37 weeks
Intrahepatic cholestasis of pregnancy complication
Stillbirth
Acute fatty liver of pregnancy features
- abdominal pain
- nausea & vomiting
- headache
- jaundice
- hypoglycaemia
- severe disease may result in pre-eclampsia
Investigation for Acute fatty liver of pregnancy
Elevated ALT e.g. 500 u/l
Management of acute fatty liver of pregnancy
- support care
- once stabilised delivery is the definitive management
Screening for anaemia in pregnancy
- The booking visit (8-10 weeks) AND
- 28 weeks
Cut-offs for oral iron therapy in pregnancy
- First trimester< 110 g/L
- Second/third trimester< 105 g/L
- Postpartum< 100 g/L
Management of anaemia in pregnancy
- oral ferrous sulfate or ferrous fumarate
- Continue Tx for 3 months after iron deficiency is corrected to allow iron stores to be replenished
Pathophysiology of acute fatty liver of pregnancy
- Due to long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency in the fetus (AD)
- Fetus and placenta are unable to break down fatty acids.
- Fatty acids enter maternal circulation, and accumulate in liver → inflammation and liver failure.
The combined test
- Between 11 - 13+6 weeks
- NT + serum B-HCG + PAPP-A
Combined test findings for Down’s, Edwards and Pataus
- Down’s syndrome = ↑ HCG, ↓ PAPP-A, thickened NT
- Edward (18) and Patau (13) give similar results but hCG tends to lower
The quadruple test
- 15 - 20 weeks
- AFP, unconjugated oestriol, B-HCG and inhibin A
Quadruple test findings for Down’s, Edwards and Pataus
What is meant by ‘lower chance’ and ‘higher chance’ on combined and quadruple test results
- ‘lower chance’: 1 in 150 chance or more e.g. 1 in 300
- ‘higher chance’: 1 in 150 chance or less e.g. 1 in 100
‘Higher chance results’ next steps
Offered NIPT or a diagnostic test (e.g. amniocentesis or CVS)
NIPT
- analyses cell free fetal DNA, cffDNA → Derived from placental cells and identical to fetal DNA
- High sensitivity and specificity (esp for trisomy 21)
CVS vs amniocentesis
- CVS → USSguided biopsy of the placental tissue. Used when testing is done earlier in pregnancy (before 15 weeks), 2% risk miscarriage
- Amniocentesis → USS-guided aspiration of amniotic fluid. Used later in pregnancy, 1% risk miscarriage
ABRUPTION
RF for placental abruption
- Abruption previously
- BP (i.e. Htn or pre-eclampsia);
- Ruptured membranes (premature or prolonged)
- Uterine injury
- Polyhydramnios;
- Twins
- Infection
- Older age (>35)
- Narcotic use (i.e. cocaine, smoking)
Clinical features of placental abruption
- Sudden onset, continue severe abdo pain
- Vaginal bleeding
- Shock
- CTG indicating fetal distress
- “woody” abdomen on palpation →large haemorrhage
Concealed vs revealed abruption
Concealed: cervical OS closed, most bleeding remains within uterine cavity
Revealed: blood loss is observed via vagina
7: ECB CF CC
Initial steps to manage major haemorrhage
- Escalate to senior obstetrician, midwife, anaesthetist
- 2x grey cannula
- Bloods - FBC, UE, LFT, coagulation studies
- Crossmatch 4 units of blood
- Fluid and blood resus as required
- CTG monitoring of foetus
- Close monitoring of mother
Definitive Mx of abruption
Fetus alive and < 36 weeks
- fetal distress: immediate caesarean
- no fetal distress: observe closely, steroids, no tocolysis, threshold to deliver depends on gestation
Fetus alive and > 36 weeks
- fetal distress: immediate caesarean
- no fetal distress: deliver vaginally
Fetus dead
- induce vaginal delivery
How to determine what dose of Anti-D prophylaxis is required
Kleihaur test to quantify amount of Fatal blood mixed with maternal blood → determine dose of Anti-D
Maternal complications of abruption
- shock
- DIC
- renal failure
- PPH
foetal complications of abruption
- IUGR
- hypoxia
- death
RF for GD
- BMI of > 30 kg/m²
- previous macrosomic baby weighing 4.5 kg or above
- previous gestational diabetes
- first-degree relative with diabetes
- family origin with a high prevalence of diabetes (South Asian, black Caribbean and Middle Eastern)
Screening for GD
OGTT
- Previous GD → perform OGTT asap after Booking AND at 24-28 weeks if first test is normal
- Any of the other risk factors → OGTT at 24-28 weeks
Diagnosis of GD
- fasting glucose is >= 5.6 mmol/L
- 2-hour glucose is >= 7.8 mmol/L
Mx of GD
<7mmol/l
- Trial of diet and exercise for 1-2 weeks
- Metformin
- Short acting insulin
>7mmol/l → Insulin
>6 mmol/l + complications ie. macrosomia or hydramnios → Insulin
Management of pre-existing diabetes
- weight loss if BMI > 27 kg/m^2
- Stop oral hypoglycaemics, apart from metformin, and commence insulin
- folic acid 5 mg/day from pre-conception to 12 weeks gestation
- detailed anomaly scan at 20 weeks incl four-chamber view of heart and outflow tracts
- tight glycaemic control reduces complication rates
- treat retinopathy as can worsen during pregnancy
Targets for self monitoring of pregnant women (pre-existing and gestational diabetes)
Alternative to metformin or insulin for GD
Glibenclamide (a sulfonylurea)
Retinopathy screening for pre-existing diabetes in pregnancy
Should be performed shortly after booking AND at 28 weeks
CHAT
High RF for pre-eclampsia
- CKD
- Hypertensive disease in previous pregnancy or pre-existing Htn
- Autoimmune disorders (SLE, APS)
- Type 1 or type 2 Diabetes
Moderate RF for pre-eclampsia
BMI > 35
Age > 40
Multiple pregnancy
First pregnancy or >10 years since last pregnancy
FxH of pre-eclampsia
How to rule out pre-eclampsia
Placental growth factor (PlGF) between 20-35 weeks to rule of pre-eclampsia
In pre-eclampsia PlGF is LOW
Scoring system to determine whether woman with pre-eclampsia should be admitted
fullPIERS and PREP-S
Medical Mx of pre-eclampsia
- Labetolol
- Nifedipine (modified-release)
- Methyldopa (stop within two days of birth)
Severe pre-eclampsia OR eclampsia → hydralazine may be used as an antihypertensive in critical care in severe pre-eclampsia or eclampsia
During labour → IV magnesium sulphate (cont for 24 hours afterwards)
Fluid restriction is used during labour in severe pre-eclampsia or eclampsia, to avoid fluid overload
The Bishop scoring system
- Assess the need for induction
- Position, consistency, effacement and dilatation and foetal station
- Score < 5 means induction will likely be necessary
- Score ≥ 8 indicates labour will likely occur spontaneously
Indications for Induction of labour
- Prolonged pregnancy
- PPROM, where labour does not start
- Diabetic mother > 38 weeks
- Pre-eclampsia
- Rhesus incompatibility
Induction methods
- vaginal prostaglandin E2 (PGE2)
- membrane sweep
- maternal oxytocin infusion
- amniotomy
- cervical ripening balloon
Main complication of induction of labour
Management
Uterine hyperstimulation
Mx
- Remove vaginal prostaglandin and stop oxytocin.
- Start tocolysis with terbutaline
Causes of Increased AFP
- NTD
- Abdominal wall defects
- Multiple pregnancy
Causes of Decreased AFP
- Down’s syndrome
- Trisomy 18
- Maternal diabetes mellitus
3 types of placenta accreta
- accreta: chorionic villi attach to myometrium
- increta: chorionic villi invade the myometrium
- percreta: chorionic villi invade through the perimetrium
Screening for postpartum depression
Edinburgh Postnatal Depression Scale
Causes of folic acid deficiency
- phenytoin
- methotrexate
- pregnancy
- alcohol excess
Prevention of NTD during pregnancy
- All women should take 400mcg of folic acid until 12th week of pregnancy
- High risk woman should take 5mg of folic acid from before conception until the 12th week of pregnancy
High risk for NTD
- Either partner has a NTD
- Previous pregnancy with NTD
- FxH of NTD
- Antiepileptic drugs
- Coeliac disease, diabetes, or thalassaemia trait
- BMI of 30 kg/m2 or more
PPH primary vs secondary
PPH is blood loss of > 500 ml after a vaginal delivery
- Primary within 24 hours
- Secondary PPH occurs between 24 hours - 6 weeks
Risk factors for primary PPH
- previous PPH
- prolonged labour
- pre-eclampsia
- Emergency C-section
- placenta praevia, placenta accreta
Management of PPH
RA drugs safe in pregnancy
sulfasalazine and hydroxychloroquine
When to stop Methotrexate
Both partners should stop 6 months before trying to conceive
Clinical features of Placenta praevia
- shock in proportion to visible loss
- no pain
- uterus not tender
- lie and presentation may be abnormal
Diagnosis of placenta praevia
20-week anomaly scan to diagnose placenta praevia
Repeat TVS at:
- 32 weeks gestation
- 36 weeks gestation (if present at 32-week scan,
RCOG definitions of placenta praevia
- Low-lying placenta → placenta is within 20mm of internal cervical os
- Placenta praevia → placenta is over the internal cervical os
Classical grading of placenta praevia
- I - placenta reaches lower segment but not the internal os
- II - placenta reaches internal os but doesn’t cover it
- III - placenta covers the internal os before dilation but not when dilated
- IV (‘major’) - placenta completely covers the internal os
Management of placenta praevia
- Elective c-section for grades III/IV at 37-38 weeks
- If grade I then trial of vaginal delivery may be offered
If a woman with known placenta praevia goes into labour prior to elective c-section → emergency c-section
Mx of placenta praevia with bleeding
- admit
- ABC approach to stabilise the woman
- if not able to stabilise → emergency caesarean section
- if in labour or term reached → emergency caesarean section
2 absolute indications for a C-section
- absolute cephalopelvic disproportion
- placenta praevia grades 3/4
Planned VBAC
Appropriate method of delivery for women at >= 37 weeks with a single previous Caesarean delivery
2 CI to VBAC
- Previous uterine rupture
- Classical caesarean scar
Anti-D routine IM injections
Rhesus negative mothers
- 28 weeks
- Birth (if babies blood group found to be positive)
Anti-D additional indications ie. sensitising events
- antepartum haemorrhage
- amniocentesis
- abdominal trauma
Within what timeframe of a sensitising event is Anti-D given
72 hours